MNA
VPHM

Manning & Napier Advisors’s VIROPHARMA INC VPHM Stock Holding History

Manning & Napier Advisors’s Portfolio VPHM Stock Details VPHM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-469,810
Closed -$13.5M – 360
2013
Q2 		$13.5M Buy
+469,810
New +$12.4M 0.07% 130

Other funds holding VPHM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Manning & Napier Advisors's VPHM Position: Q3 2013 in Review

Manning & Napier Advisors sold out of VIROPHARMA INC (VPHM) in Q3 2013, closing a stake of 469,810 shares — an estimated $13.5M sold.

Manning & Napier Advisors first reported a position in VPHM in Q2 2013 and held it in 1 quarter. The position peaked at $13.5M in Q2 2013. 191 funds tracked by Wall St. Rank hold VPHM as of Q3 2013.

  • Manning & Napier Advisors reported no remaining VIROPHARMA INC position as of Q3 2013 after selling out during the quarter.
  • Manning & Napier Advisors sold 469,810 VIROPHARMA INC shares in Q3 2013, an estimated $13.5M.
  • Manning & Napier Advisors first reported a position in VIROPHARMA INC in Q2 2013 and held it in 1 quarter.
  • Manning & Napier Advisors's VIROPHARMA INC position peaked at $13.5M in Q2 2013.
  • 191 funds tracked by Wall St. Rank held VIROPHARMA INC as of Q3 2013.

Based on Manning & Napier Advisors's 13F filing for Q3 2013, filed 18 Oct 2013.